Akebia Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Akebia Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Akebia Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was -730 %, a 51.5% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -730 +775 +51.5% Sep 30, 2024
Q2 2024 -804 +3.41K +80.9% Jun 30, 2024
Q1 2024 -870 -3.79K -130% Mar 31, 2024
Q4 2023 -972 -2.84K -152% Dec 31, 2023
Q3 2023 -1.51K -2.65K -231% Sep 30, 2023
Q2 2023 -4.22K -4.87K -746% Jun 30, 2023
Q1 2023 2.92K +2.46K +536% Mar 31, 2023
Q4 2022 1.87K +1.57K +533% Dec 31, 2022
Q3 2022 1.15K +926 +416% Sep 30, 2022
Q2 2022 653 +484 +286% Jun 30, 2022
Q1 2022 460 +325 +241% Mar 31, 2022
Q4 2021 296 +181 +158% Dec 31, 2021
Q3 2021 223 +121 +119% Sep 30, 2021
Q2 2021 169 +78.6 +87% Jun 30, 2021
Q1 2021 135 +55.9 +71% Mar 31, 2021
Q4 2020 114 +46 +67.1% Dec 31, 2020
Q3 2020 102 +41.4 +68.9% Sep 30, 2020
Q2 2020 90.4 +23.3 +34.7% Jun 30, 2020
Q1 2020 78.8 -0.24 -0.3% Mar 31, 2020
Q4 2019 68.5 -29.2 -29.9% Dec 31, 2019
Q3 2019 60.2 -98.5 -62.1% Sep 30, 2019
Q2 2019 67.1 -99.3 -59.7% Jun 30, 2019
Q1 2019 79 -132 -62.5% Mar 31, 2019
Q4 2018 97.7 -221 -69.4% Dec 31, 2018
Q3 2018 159 -224 -58.6% Sep 30, 2018
Q2 2018 166 -149 -47.3% Jun 30, 2018
Q1 2018 211 +33.3 +18.7% Mar 31, 2018
Q4 2017 319 +230 +260% Dec 31, 2017
Q3 2017 383 +346 +939% Sep 30, 2017
Q2 2017 315 +291 +1182% Jun 30, 2017
Q1 2017 178 +163 +1132% Mar 31, 2017
Q4 2016 88.7 +80.8 +1029% Dec 31, 2016
Q3 2016 36.9 +29.6 +408% Sep 30, 2016
Q2 2016 24.6 +18.5 +303% Jun 30, 2016
Q1 2016 14.4 +8.18 +131% Mar 31, 2016
Q4 2015 7.85 +2.62 +50.1% Dec 31, 2015
Q3 2015 7.26 -1.82 -20% Sep 30, 2015
Q2 2015 6.11 Jun 30, 2015
Q1 2015 6.25 Mar 31, 2015
Q4 2014 5.23 Dec 31, 2014
Q3 2014 9.08 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.